AltruBio nets $63m Series A

AltruBio Inc, a clinical-stage biotech company, has raised $63 million in Series A financing.

AltruBio Inc, a clinical-stage biotech company, has raised $63 million in Series A financing. The lead investor was aMoon. Other investors in the round included BVF Partners and CAM Capital.

Source: Press Release